Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Marfan syndrome in adolescence: adolescents' perspectives on (physical) functioning, disability, contextual factors and support needs.

Warnink-Kavelaars J, Beelen A, Goedhart TMHJ, de Koning LE, Nollet F, Alsem MW, Menke LA, Engelbert RHH.

Eur J Pediatr. 2019 Oct 16. doi: 10.1007/s00431-019-03469-7. [Epub ahead of print]

PMID:
31620888
2.

Vegetative Cell and Spore Proteomes of Clostridioides difficile Show Finite Differences and Reveal Potential Protein Markers.

Abhyankar WR, Zheng L, Brul S, de Koster CG, de Koning LJ.

J Proteome Res. 2019 Nov 1;18(11):3967-3976. doi: 10.1021/acs.jproteome.9b00413. Epub 2019 Oct 14.

3.

Survey of the initial management of celiac disease antibody tests by ordering physicians.

Potter K, de Koning L, Butzner JD, Gidrewicz D.

BMC Pediatr. 2019 Jul 19;19(1):243. doi: 10.1186/s12887-019-1621-5.

4.

Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization.

Schueler J, Tschuch C, Klingner K, Bug D, Peille AL, de Koning L, Oswald E, Klett H, Sommergruber W.

Cells. 2019 Jul 18;8(7). pii: E740. doi: 10.3390/cells8070740.

5.

Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models.

Biau J, Chautard E, Berthault N, de Koning L, Court F, Pereira B, Verrelle P, Dutreix M.

Front Oncol. 2019 Jun 19;9:549. doi: 10.3389/fonc.2019.00549. eCollection 2019.

6.

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.

de Koning L, Decaudin D, El Botty R, Nicolas A, Carita G, Schuller M, Ouine B, Cartier A, Naguez A, Fleury J, Cooke V, Wylie A, Smith P, Marangoni E, Gentien D, Meseure D, Mariani P, Cassoux N, Piperno-Neumann S, Roman-Roman S, Némati F.

Cancers (Basel). 2019 May 29;11(6). pii: E751. doi: 10.3390/cancers11060751.

7.

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.

Caruso S, Calatayud AL, Pilet J, La Bella T, Rekik S, Imbeaud S, Letouzé E, Meunier L, Bayard Q, Rohr-Udilova N, Péneau C, Grasl-Kraupp B, de Koning L, Ouine B, Bioulac-Sage P, Couchy G, Calderaro J, Nault JC, Zucman-Rossi J, Rebouissou S.

Gastroenterology. 2019 Sep;157(3):760-776. doi: 10.1053/j.gastro.2019.05.001. Epub 2019 May 4.

PMID:
31063779
8.

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Campo ERD, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, von der Leyen H, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M.

EBioMedicine. 2019 May;43:253-260. doi: 10.1016/j.ebiom.2019.03.069. Epub 2019 Apr 2.

9.

Proteomics and microscopy tools for the study of antimicrobial resistance and germination mechanisms of bacterial spores.

Abhyankar WR, Wen J, Swarge BN, Tu Z, de Boer R, Smelt JPPM, de Koning LJ, Manders E, de Koster CG, Brul S.

Food Microbiol. 2019 Aug;81:89-96. doi: 10.1016/j.fm.2018.03.006. Epub 2018 Mar 14. Review.

10.

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications.

Blum Y, Meiller C, Quetel L, Elarouci N, Ayadi M, Tashtanbaeva D, Armenoult L, Montagne F, Tranchant R, Renier A, de Koning L, Copin MC, Hofman P, Hofman V, Porte H, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, de Reyniès A, Jean D.

Nat Commun. 2019 Mar 22;10(1):1333. doi: 10.1038/s41467-019-09307-6.

11.

Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults.

Malik VS, Li Y, Pan A, De Koning L, Schernhammer E, Willett WC, Hu FB.

Circulation. 2019 Apr 30;139(18):2113-2125. doi: 10.1161/CIRCULATIONAHA.118.037401.

PMID:
30882235
12.

A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.

Coussy F, de Koning L, Lavigne M, Bernard V, Ouine B, Boulai A, El Botty R, Dahmani A, Montaudon E, Assayag F, Morisset L, Huguet L, Sourd L, Painsec P, Callens C, Chateau-Joubert S, Servely JL, Larcher T, Reyes C, Girard E, Pierron G, Laurent C, Vacher S, Baulande S, Melaabi S, Vincent-Salomon A, Gentien D, Dieras V, Bieche I, Marangoni E.

Int J Cancer. 2019 Oct 1;145(7):1902-1912. doi: 10.1002/ijc.32266. Epub 2019 Apr 4.

PMID:
30859564
13.

Strategies for mitigating risk posed by biotin interference on clinical immunoassays.

Gifford JL, de Koning L, Sadrzadeh SMH.

Clin Biochem. 2019 Mar;65:61-63. doi: 10.1016/j.clinbiochem.2018.12.007. Epub 2018 Dec 21.

PMID:
30582902
14.

Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma.

Tranchant R, Quetel L, Montagne F, De Wolf J, Meiller C, De Koning L, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Lung Cancer. 2018 Dec;126:15-24. doi: 10.1016/j.lungcan.2018.10.015. Epub 2018 Oct 16.

PMID:
30527180
15.

Mapping the Contact Sites of the Escherichia coli Division-Initiating Proteins FtsZ and ZapA by BAMG Cross-Linking and Site-Directed Mutagenesis.

Roseboom W, Nazir MG, Meiresonne NY, Mohammadi T, Verheul J, Buncherd H, Bonvin AMJJ, de Koning LJ, de Koster CG, de Jong L, den Blaauwen T.

Int J Mol Sci. 2018 Sep 26;19(10). pii: E2928. doi: 10.3390/ijms19102928.

16.

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition.

El Botty R, Coussy F, Hatem R, Assayag F, Chateau-Joubert S, Servely JL, Leboucher S, Fouillade C, Vacher S, Ouine B, Cartier A, de Koning L, Cottu P, Bièche I, Marangoni E.

Oncotarget. 2018 Jul 3;9(51):29587-29600. doi: 10.18632/oncotarget.25640. eCollection 2018 Jul 3.

17.

Reverse Phase Protein array for the quantification and validation of protein biomarkers of beef qualities: The case of meat color from Charolais breed.

Gagaoua M, Bonnet M, De Koning L, Picard B.

Meat Sci. 2018 Nov;145:308-319. doi: 10.1016/j.meatsci.2018.06.039. Epub 2018 Jul 5.

PMID:
30015160
18.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Aug;119(3):387. doi: 10.1038/s41416-018-0130-x.

19.

Beef tenderness and intramuscular fat proteomic biomarkers: muscle type effect.

Picard B, Gagaoua M, Al-Jammas M, De Koning L, Valais A, Bonnet M.

PeerJ. 2018 Jun 7;6:e4891. doi: 10.7717/peerj.4891. eCollection 2018.

20.

Correction to "Stoichiometry, Absolute Abundance, and Localization of Proteins in the Bacillus cereus Spore Coat Insoluble Fraction Determined Using a QconCAT Approach".

Stelder SK, Benito de Moya C, Hoefsloot HCJ, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2018 Jul 6;17(7):2562. doi: 10.1021/acs.jproteome.8b00313. Epub 2018 Jun 1. No abstract available.

21.

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.

Maubant S, Tahtouh T, Brisson A, Maire V, Némati F, Tesson B, Ye M, Rigaill G, Noizet M, Dumont A, Gentien D, Marty-Prouvost B, de Koning L, Mahmood SF, Decaudin D, Cruzalegui F, Tucker GC, Roman-Roman S, Dubois T.

Oncotarget. 2018 Apr 27;9(32):22586-22604. doi: 10.18632/oncotarget.25187. eCollection 2018 Apr 27.

22.

"One-Pot" Sample Processing Method for Proteome-Wide Analysis of Microbial Cells and Spores.

Swarge BN, Roseboom W, Zheng L, Abhyankar WR, Brul S, de Koster CG, de Koning LJ.

Proteomics Clin Appl. 2018 Sep;12(5):e1700169. doi: 10.1002/prca.201700169. Epub 2018 Apr 16.

23.

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis.

Lallemand F, Petitalot A, Vacher S, de Koning L, Taouis K, Lopez BS, Zinn-Justin S, Dalla-Venezia N, Chemlali W, Schnitzler A, Lidereau R, Bieche I, Caputo SM.

Oncotarget. 2017 Dec 30;9(7):7464-7475. doi: 10.18632/oncotarget.23779. eCollection 2018 Jan 26.

24.

Reverse phase protein arrays for the identification/validation of biomarkers of beef texture and their use for early classification of carcasses.

Gagaoua M, Bonnet M, Ellies-Oury MP, De Koning L, Picard B.

Food Chem. 2018 Jun 1;250:245-252. doi: 10.1016/j.foodchem.2018.01.070. Epub 2018 Jan 10.

PMID:
29412918
25.

Stoichiometry, Absolute Abundance, and Localization of Proteins in the Bacillus cereus Spore Coat Insoluble Fraction Determined Using a QconCAT Approach.

Stelder SK, Benito de Moya C, Hoefsloot HCJ, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2018 Feb 2;17(2):903-917. doi: 10.1021/acs.jproteome.7b00732. Epub 2018 Jan 4. Erratum in: J Proteome Res. 2018 Jul 6;17(7):2562.

26.

Stabilizing specimens for routine ammonia testing in the clinical laboratory.

Gifford JL, Nguyen WNT, de Koning L, Seiden-Long I.

Clin Chim Acta. 2018 Mar;478:37-43. doi: 10.1016/j.cca.2017.12.022. Epub 2017 Dec 16.

PMID:
29258744
27.

[Hypersensitivity reactions and vaccines].

Geersing TH, Hilgersom WJA, Tempels-Pavlica Ž, Rümke HC, de Koning LCMJ, Borgsteede SD.

Ned Tijdschr Geneeskd. 2017;161:D1491. Review. Dutch.

PMID:
29219793
28.

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2017 Dec 5;117(12):1819-1827. doi: 10.1038/bjc.2017.353. Epub 2017 Oct 12. Erratum in: Br J Cancer. 2018 Aug;119(3):387.

29.

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.

Neuzillet Y, Chapeaublanc E, Krucker C, De Koning L, Lebret T, Radvanyi F, Bernard-Pierrot I.

BMC Cancer. 2017 Sep 7;17(1):636. doi: 10.1186/s12885-017-3618-5.

30.

Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma.

Biau J, Chautard E, De Koning L, Court F, Pereira B, Verrelle P, Dutreix M.

Radiat Oncol. 2017 Jul 28;12(1):123. doi: 10.1186/s13014-017-0858-0.

31.

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, de Koning L, Delgado-Lista J, Díaz-López A, Drevon CA, Estruch R, Esposito K, Fitó M, Garaulet M, Giugliano D, García-Ríos A, Katsiki N, Kolovou G, Lamarche B, Maiorino MI, Mena-Sánchez G, Muñoz-Garach A, Nikolic D, Ordovás JM, Pérez-Jiménez F, Rizzo M, Salas-Salvadó J, Schröder H, Tinahones FJ, de la Torre R, van Ommen B, Wopereis S, Ros E, López-Miranda J.

Nutr Rev. 2017 May 1;75(5):307-326. doi: 10.1093/nutrit/nux014.

32.

Acceleration-based training: A new mode of training in senescent rats improving performance and left ventricular and muscle functions.

Launay T, Momken I, Carreira S, Mougenot N, Zhou XL, De Koning L, Niel R, Riou B, Billat V, Besse S.

Exp Gerontol. 2017 Sep;95:71-76. doi: 10.1016/j.exger.2017.05.002. Epub 2017 May 4.

PMID:
28479388
33.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Rebouissou S, La Bella T, Rekik S, Imbeaud S, Calatayud AL, Rohr-Udilova N, Martin Y, Couchy G, Bioulac-Sage P, Grasl-Kraupp B, de Koning L, Ganne-Carrié N, Nault JC, Ziol M, Zucman-Rossi J.

Clin Cancer Res. 2017 Aug 1;23(15):4364-4375. doi: 10.1158/1078-0432.CCR-16-3118. Epub 2017 Feb 28.

34.

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma.

Tranchant R, Quetel L, Tallet A, Meiller C, Renier A, de Koning L, de Reynies A, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Clin Cancer Res. 2017 Jun 15;23(12):3191-3202. doi: 10.1158/1078-0432.CCR-16-1971. Epub 2016 Dec 21.

35.

Critically High Plasma Ammonia in an Adolescent Girl.

Orton DJ, Gifford JL, Seiden-Long I, Khan A, de Koning L.

Clin Chem. 2016 Dec;62(12):1565-1568. No abstract available.

36.

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.

Samuels S, Balint B, von der Leyen H, Hupé P, de Koning L, Kamoun C, Luscap-Rondof W, Wittkop U, Bagrintseva K, Popovic M, Kereszt A, Berns E, Kenter GG, Jordanova ES, Kamal M, Scholl S.

Br J Cancer. 2016 Dec 6;115(12):1575-1583. doi: 10.1038/bjc.2016.340. Epub 2016 Nov 22.

37.

Serum Total 25-OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization.

Gerling ME, James MT, Wilton SB, Naugler C, Southern DA, Galbraith PD, Knudtson M, de Koning L.

J Am Heart Assoc. 2016 Oct 21;5(10). pii: e004289.

38.

The Influence of Sporulation Conditions on the Spore Coat Protein Composition of Bacillus subtilis Spores.

Abhyankar WR, Kamphorst K, Swarge BN, van Veen H, van der Wel NN, Brul S, de Koster CG, de Koning LJ.

Front Microbiol. 2016 Oct 13;7:1636. eCollection 2016.

39.

Global Conservation of Protein Status between Cell Lines and Xenografts.

Biau J, Chautard E, Court F, Pereira B, Verrelle P, Devun F, De Koning L, Dutreix M.

Transl Oncol. 2016 Aug;9(4):313-21. doi: 10.1016/j.tranon.2016.05.005.

40.

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.

Carita G, Frisch-Dit-Leitz E, Dahmani A, Raymondie C, Cassoux N, Piperno-Neumann S, Némati F, Laurent C, De Koning L, Halilovic E, Jeay S, Wylie A, Emery C, Roman-Roman S, Schoumacher M, Decaudin D.

Oncotarget. 2016 Jun 7;7(23):33542-56. doi: 10.18632/oncotarget.9552.

41.

Maternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women.

Heng YJ, Pennell CE, McDonald SW, Vinturache AE, Xu J, Lee MW, Briollais L, Lyon AW, Slater DM, Bocking AD, de Koning L, Olson DM, Dolan SM, Tough SC, Lye SJ.

PLoS One. 2016 Jun 22;11(6):e0155191. doi: 10.1371/journal.pone.0155191. eCollection 2016.

42.

'Omics' for microbial food stability: Proteomics for the development of predictive models for bacterial spore stress survival and outgrowth.

Abhyankar W, Stelder S, de Koning L, de Koster C, Brul S.

Int J Food Microbiol. 2017 Jan 2;240:11-18. doi: 10.1016/j.ijfoodmicro.2016.05.008. Epub 2016 May 7. Review.

PMID:
27296564
43.

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers.

Prunier C, Josserand V, Vollaire J, Beerling E, Petropoulos C, Destaing O, Montemagno C, Hurbin A, Prudent R, de Koning L, Kapur R, Cohen PA, Albiges-Rizo C, Coll JL, van Rheenen J, Billaud M, Lafanechère L.

Cancer Res. 2016 Jun 15;76(12):3541-52. doi: 10.1158/0008-5472.CAN-15-1864. Epub 2016 May 23.

44.

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.

Meseure D, Vacher S, Lallemand F, Alsibai KD, Hatem R, Chemlali W, Nicolas A, De Koning L, Pasmant E, Callens C, Lidereau R, Morillon A, Bieche I.

Br J Cancer. 2016 Jun 14;114(12):1395-404. doi: 10.1038/bjc.2016.123. Epub 2016 May 12.

45.

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan N, Middleton G, Quezada SA, Rodón J, Rosenfeld N, Sotiriou C, André F.

Ann Oncol. 2016 Aug;27(8):1443-8. doi: 10.1093/annonc/mdw192. Epub 2016 May 3.

PMID:
27143638
46.

Arpin downregulation in breast cancer is associated with poor prognosis.

Lomakina ME, Lallemand F, Vacher S, Molinie N, Dang I, Cacheux W, Chipysheva TA, Ermilova VD, de Koning L, Dubois T, Bièche I, Alexandrova AY, Gautreau A.

Br J Cancer. 2016 Mar 1;114(5):545-53. doi: 10.1038/bjc.2016.18. Epub 2016 Feb 11.

47.

AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.

Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, Mechta-Grigoriou F, Del Maestro L, Chavrier P, Vallerand D, Brito I, Dubois T, De Koning L, Bouvard D, Louvard D, Gautreau A, Lallemand D.

Neoplasia. 2016 Jan;18(1):10-24. doi: 10.1016/j.neo.2015.11.010.

48.

Bacillus subtilis Spore Inner Membrane Proteome.

Zheng L, Abhyankar W, Ouwerling N, Dekker HL, van Veen H, van der Wel NN, Roseboom W, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2016 Feb 5;15(2):585-94. doi: 10.1021/acs.jproteome.5b00976. Epub 2016 Jan 13.

PMID:
26731423
49.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR, Gaber A, O'Hurley G, Lehn S, Muris JJ, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O'Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Sci Rep. 2016 Jan 5;6:18517. doi: 10.1038/srep18517.

50.

Risk prediction models for acute kidney injury following major noncardiac surgery: systematic review.

Wilson T, Quan S, Cheema K, Zarnke K, Quinn R, de Koning L, Dixon E, Pannu N, James MT.

Nephrol Dial Transplant. 2016 Feb;31(2):231-40. doi: 10.1093/ndt/gfv415. Epub 2015 Dec 24. Review.

PMID:
26705194

Supplemental Content

Loading ...
Support Center